The initial study on microRNA expression profile in human colorectal cancer with liver metastasis
10.3760/cma.j.issn.0254-1432.2010.11.009
- VernacularTitle:人肝转移结直肠癌微小核糖核酸表达谱的初步研究
- Author:
Maosong LIN
;
Weichang CHEN
;
Junxing HUANG
;
Jiayi ZHU
;
Bin YANG
;
Yulan YE
;
Hengjun GAO
;
Zhenyun SONG
;
Xiaoying SHEN
- Publication Type:Journal Article
- Keywords:
Colorectal neoplasms;
MicroRNAs;
Neoplasms metastasis
- From:
Chinese Journal of Digestion
2010;30(11):819-823
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the microRNAs expression profile in human colorectal cancer with or without liver metastasis and try to screen miRNA associated with liver metastasis in colorectal cancer. Methods Twenty five surgical resected colorectal cancer specimens were collected and frozen in liquid nitrogen. Three without liver metastasis and three with liver metastasis were selected, from which total RNAs were isolated. The expressions of miRNAs in these two types of specimens were detected by illumine microRNA microarray, and the difference of miRNA expression was screened. The biochip results were verified with real-time RT-PCR in all colorectal caner specimens. Results The miRNA expression was significantly different in colorectal cancer with liver metastasis and without liver metastasis. Compared with colorectal cancer without liver metastasis, 28 miRNA expressions was different in colorectal cancer with liver metastasis, 4 up regulated and 24 down regulated. The quantity of miR-139-3p expression in colorectal cancer with liver metastasis was 1.75±0.40, up regulated compared with that incolorectal cancer without liver metastasis(0. 69 ±0.58,P＜0.05). The quantity of miR-19a expression in liver metastasis was 0. 39±0. 20, downregulated compare with no liver metastasis( 1.38 ± 0.98, P＜0. 05). The result of miRNA biochip was consistent with that of RT-PCR. Conclusion The difference of miRNA expression might relate to liver metastasis of colorectal cancer. The specific miRNAs expression profile might provide new target for diagnosis and treatment of colorectal cancer with liver metastasis.
